Want to contact a Zelnorm lawyer in District of Columbia? ...Get a free case evaluation from one of our Zelnorm lawyers in District of Columbia now.
Home : Unsafe Drugs : Zelnorm : News Articles
Zelnorm - News Articles
-
Oct 18, 2007
BBC News, UK -
Novartis said its sales had been hit by its bowel drug Zelnorm being withdrawn in the US in March, as well as the launch of generic versions of three of its medicines. It added that the job cuts would lead to annual savings of about $230m. ... -
Oct 18, 2007
Reuters.uk, UK -
Net profit fell by 12 percent to $1.57 billion, hit by the loss of bowel drug Zelnorm, which was withdrawn from sale in the United States, and launches of generic versions of three ofNovartis's medicines, Famvir, Lotrel and Lamisil. Basel-based Novartis also announced a management shake-up,saying the ... -
Oct 18, 2007
MarketWatch -
sales in the US for constipation treatment Zelnorm and US generic competition for blood-pressure medicine Lotril, fungal treatment Lamisil and Farnvir. ... -
Oct 18, 2007
Euronews.net, France -
In addition income suffered due to the suspension from sale in the US of a bowel drug Zelnorm. Analysts seemed pleased with the figures. One said he thought the weaker third quarter results mark the bottoming out for Novartis, which expects that new ... -
Oct 19, 2007
Toronto Star, Canada -
company's medical nutrition and Gerber units. Profit from continuing operations was hurt by such things as the withdrawal of the Zelnorm bowel treatment. ... -
Oct 17, 2007
Bloomberg -
Sales were hurt by the withdrawal of Zelnorm and the start of generic competition to heart medicine Lotrel, genital herpes treatment Famvir and anti- fungal ... -
Sep 21, 2007
BioWorld Online, GA -
from investors earlier this year, when Novartis AG withdrew Zelnorm (tegaserod) because of concerns regarding possible cardiovascular side effects. "I think it's been clear for a long time, the number of patients unsatisfied with current therapies," Hecht ... -
Sep 13, 2007
Pharma Times (subscription), UK -
time to recover from the withdrawal of the irritable bowel syndrome drug Zelnorm (tegaserod) after it was linked to possible heart attacks and strokes. ... -
Sep 12, 2007
Reuters -
However, the second half of 2007 and first half of 2008 will continue to be impacted by the suspension of bowel drug Zelnorm and generic competition. ... -
Sep 12, 2007
Forbes, NY -
during the second half of 2007 and the first half of next year will still be hampered by the recent suspension of irritable bowel syndrome drug Zelnorm. It will also be affected by competition from new generic versions of key drugs ...
-
Sep 17, 2007
Daily Record (subscription), MD -
In March, Zelnorm, Amitiza’s chief competition among prescription drugs for constipation, was pulled from the market by its maker, Novartis, after the drug ... -
Sep 16, 2007
CNNMoney.com -
of competition from generic drug makers for some of its key medicines as well as the US suspension of Zelnorm, a treatment for irritable bowel syndrome. andrew.ge.thompson@thomson.com Copyright Thomson Financial News Limited 2007. All rights reserved. The copying, republication or redistribution of Thomson ... -
Sep 17, 2007
CNNMoney.com -
The Basel-based drug maker has been hit by the suspension of constipation drug Zelnorm as well as by generic competition for some of its key drugs. But last Wednesday, Novartis has projected that it should return to 'strong' growth territory by ... -
Sep 17, 2007
BioWorld Online, GA -
"We've been after this opportunity for three or four years," he added, noting that the "enthusiasm Novartis received for Zelnorm was a good indication of how big the unmet patient need is." Microbia and Forest will split U.S. development and marketing costs as well ... -
Sep 12, 2007
Forbes, NY -
Zelnorm was withdrawn from the US earlier this year on safety concern but the company has since agreed a restricted access programme with the Federal Drug Administration (FDA). andrew.ge.thompson@thomson.com at/cm2/at/am COPYRIGHT Copyright AFX News Limited ... -
Sep 12, 2007
San Diego Union Tribune, United States -
However, the second half of 2007 and first half of 2008 remain difficult, due to the suspension of bowel drug Zelnorm and generic competition, notably to blood pressure drug Lotrel. Novartis has suffered a series of setbacks this year, tarnishing what should have ... -
Sep 28, 2007
Science Daily (press release) -
full story FDA to allow limited Zelnorm use (July 28, 2007) -- The US Food and Drug Administration is permitting the restricted use of Zelnorm to treat ... -
Sep 30, 2007
Pioneer Press, MN -
Frenette, 25, who was taking the drug Zelnorm for treatment of gastroparesis (paralyzed stomach) until the FDA pulled it from the US market this summer, ... -
Monday, July 30, 2007
HealthandAge.com -
This is important news for sufferers from this type of IBS, especially since the withdrawal of tegaserod (Zelnorm®). Clinical studies show that 8 microgram of lubiprostone given twice daily is effective in 17% of patients with IBS-with-constipation, compared with a placebo's effectiveness in ... -
Jul 29, 2007
Associated Content, CO -
By jacob dauler According to Novartis Pharmaceuticals Corporation, the US Food and Drug Administration and Novartis have established a program, called a treatment IND, that will allow restricted access for Zelnorm so that patients with urgent need of the ...
Want to contact a Zelnorm lawyer in District of Columbia? ...Get a free case evaluation from one of our Zelnorm lawyers in District of Columbia now.
Pages: Previous ... 2 3 4 5 6 7 8 9 10 11 12 ... Next
These articles are related to: Zelnorm, Zelnorm Claim, Zelnorm Lawsuit, Zelnorm Law Suit, Zelnorm Law Firm, Zelnorm Lawyer, Zelnorm Attorney, Zelnorm Trial, Zelnorm Verdict, Zelnorm News, Zelnorm Information, Zelnorm Lawyers, Zelnorm Litigation, Zelnorm Case, Zelnorm Side Effects, Zelnorm Recall, Zelnorm Warning, Zelnorm Abuse, Zelnorm Exposure, Zelnorm Class Action, Tegaserod, Irritable Bowel Syndrome, IBS
